# SHIVA02 - Evaluation of the Efficacy of Targeted Therapy Based on Tumor Molecular Profiling in Patients With Advanced Cancer Using Each Patient as Its Own Control (SHIVA02)

> **NCT03084757** · NA · COMPLETED · sponsor: **Institut Curie** · enrollment: 170 (actual)

## Conditions studied

- Cancer
- Solid Tumor, Adult

## Interventions

- **DIAGNOSTIC_TEST:** research of druggable molecular alterations on tumor biopsy

## Key facts

- **NCT ID:** NCT03084757
- **Lead sponsor:** Institut Curie
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-05-26
- **Primary completion:** 2022-10-20
- **Final completion:** 2024-05-31
- **Target enrollment:** 170 (ACTUAL)
- **Last updated:** 2025-08-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03084757

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03084757, "SHIVA02 - Evaluation of the Efficacy of Targeted Therapy Based on Tumor Molecular Profiling in Patients With Advanced Cancer Using Each Patient as Its Own Control (SHIVA02)". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT03084757. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*